Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670147 · ClinicalTrials.gov registry record · NA
Paresthesia Free Spinal Cord Stimulation (PF-SCS)
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03670147: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT03670147 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670147, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal is to document efficacy of PF-SCS therapy in a blinded fashion and better understand how SCS therapy works in the clinical setting. Overall the investigators hope to improve patient care and selection of candidates who have the best potential for effective pain relief from an expensive and invasive therapy.
Interventions
- DEVICE PF-SCS programming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03670147
The ClinicalTrials.gov registry entry for NCT03670147 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-SCS programming is the first listed.
NCT03670147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03670147 about?
NCT03670147 is a clinical study titled "Paresthesia Free Spinal Cord Stimulation (PF-SCS)". The goal is to document efficacy of PF-SCS therapy in a blinded fashion and better understand how SCS therapy works in the clinical setting. Overall the investigators hope to improve patient care and selection of candidates who have the best potential for effective pain relief from an expensive and ...
What is the current status of trial NCT03670147?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-12-01. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT03670147?
The interventions under investigation include: PF-SCS programming (DEVICE).
Who is sponsoring clinical trial NCT03670147?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.